These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25992768)

  • 1. Lepr(db) mouse model of type 2 diabetes: pancreatic islet isolation and live-cell 2-photon imaging of intact islets.
    Do OH; Low JT; Thorn P
    J Vis Exp; 2015 May; (99):e52632. PubMed ID: 25992768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
    Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
    Ladefoged M; Buschard K; Hansen AM
    APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
    Jeong JH; Yook S; Lee H; Ahn CH; Lee DY; Byun Y
    Biochem Biophys Res Commun; 2013 Apr; 433(4):513-8. PubMed ID: 23523788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of db gene-related pancreatic beta cell dysfunction; evidence for a compensatory mechanism inhibiting development of diabetes in the db gene heterozygote.
    Kanda Y; Shimoda M; Tawaramoto K; Hamamoto S; Tatsumi F; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
    Endocr J; 2009; 56(8):997-1008. PubMed ID: 19706988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional polarisation of human pancreatic beta cells in islets from organ donors with and without type 2 diabetes.
    Cottle L; Gan WJ; Gilroy I; Samra JS; Gill AJ; Loudovaris T; Thomas HE; Hawthorne WJ; Kebede MA; Thorn P
    Diabetologia; 2021 Mar; 64(3):618-629. PubMed ID: 33399909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of islet glutaredoxin 1 and 5 with high reactive oxygen species production in a mouse model of diabesity.
    Petry SF; Sharifpanah F; Sauer H; Linn T
    PLoS One; 2017; 12(5):e0176267. PubMed ID: 28542222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice.
    Corbin KL; Waters CD; Shaffer BK; Verrilli GM; Nunemaker CS
    Endocrinology; 2016 May; 157(5):1826-38. PubMed ID: 26943366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets.
    Sacco F; Seelig A; Humphrey SJ; Krahmer N; Volta F; Reggio A; Marchetti P; Gerdes J; Mann M
    Cell Metab; 2019 Jun; 29(6):1422-1432.e3. PubMed ID: 30879985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
    Ueda K; Tanizawa Y; Ishihara H; Kizuki N; Ohta Y; Matsutani A; Oka Y
    Diabetologia; 1998 Jun; 41(6):649-53. PubMed ID: 9662045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model.
    Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M
    Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet.
    Falcão VT; Maschio DA; de Fontes CC; Oliveira RB; Santos-Silva JC; Almeida AC; Vanzela EC; Cartaxo MT; Carvalho CP; Collares-Buzato CB
    Histochem Cell Biol; 2016 Jul; 146(1):13-31. PubMed ID: 27020567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-cell function of pancreatic islets isolated from bank voles developing glucose intolerance/diabetes: an animal model showing features of both type 1 and type 2 diabetes mellitus, and a possible role of the Ljungan virus.
    Blixt M; Niklasson B; Sandler S
    Gen Comp Endocrinol; 2007; 154(1-3):41-7. PubMed ID: 17686482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochemical analysis of pancreatic islet lipoapoptosis: hyperlipidemia-induced cytoinvolution following expression of the diabetes (db/db) mutation.
    Garris DR
    Pathobiology; 2005; 72(3):124-32. PubMed ID: 15860929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells.
    Amisten S; Mohammad Al-Amily I; Soni A; Hawkes R; Atanes P; Persaud SJ; Rorsman P; Salehi A
    Endocr J; 2017 Mar; 64(3):325-338. PubMed ID: 28228611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel culture technique involving an histone deacetylase inhibitor reduces the marginal islet mass to correct streptozotocin-induced diabetes.
    Shin JS; Min BH; Lim JY; Kim BK; Han HJ; Yoon KH; Kim SJ; Park CG
    Cell Transplant; 2011; 20(9):1321-32. PubMed ID: 21294957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.